F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland.

Beijing Saite Mingqiang Pharmaceutical Technology Co., Ltd., established on 2015-07-20, Business scope includes technology development,technology transfer,Technical Services,technical consulting;Investment Advisory;investment management;Investment;Import and export,Technology Import and Export(The above two do not include the law,Projects that require approval according to regulations),Agent import and export.(Market entities independently choose business projects in accordance with the law,Carry out business activities;The enterprise was2020year12moon31Before that date, it was a domestic-funded enterprise,2020year12moon31Change to a foreign-invested enterprise after that date;Items subject to approval by law,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the industrial policies of the state and this city.)

Part of Abbott Laboratories, Hokuriku Seiyaku Co., Ltd. is a Japanese company located in Katsuyama. The firm develops, manufactures, and sells pharmaceuticals. On June 30, 2002 Abbott Laboratories acquired Hokuriku Seiyaku Co., Ltd. for $291.31 million.

Part of Sino Biopharmaceutical Ltd., Chia Tai Tianqing Pharmaceutical Group Co., Ltd. (doing business as Chia Tai-Tianqing Pharmaceutical Co Ltd) is a company headquartered in Lianyungang, China. The firm manufactures pharmaceutical products. It was founded in 1969. Kang Xin Yu is the current CEO of the firm.

Hinova Pharma is an innovative drug research and development manufacturer that provides users with compound HC-1119 androgen receptor (AR) antagonism by using drug discovery systems such as medicinal chemistry, biological screening, process research, quality research, clinical reporting, and clinical research. Drugs, HC-1102 androgen receptor inhibitors and other products, for the treatment of advanced prostate cancer and breast cancer.

Adolor Corporation is a biopharmaceutical company focused on the discovery, development and commercialization of prescription pain and pain-management products. ENTEREG (alvimopan) is the United States Food and Drug Administration (FDA) approved product. ENTEREG is indicated to accelerate upper and lower gastrointestinal (GI) recovery following partial large or small bowel resection surgery with primary anastomosis. The Company is conducting two Phase 2 clinical trials of ADL5945 to treat opioid-induced constipation (OIC), a condition that often results from long-term use of opioid analgesics in the management of chronic pain conditions. In addition, it is continuing development efforts on ADL7445, a second peripherally-acting mu opioid receptor antagonist, which is considered a back-up compound in its OIC program. The Company has completed Phase 1 clinical evaluation of ADL6906 (beloxepin).

Merck Sharp & Dohme LLC, part of Merck & Co., Inc., is a company headquartered in Kenilworth, NJ, that operates as a pharmaceutical company.

Pierre Fabre Médicament SA manufactures cosmetics and pharmaceutical products. It focuses on research, development, and prescription of medicines and cosmetics. The company was founded on December 31, 1982 and is headquartered in Boulogne-Billancourt, France.

Shanghai Pharmaceuticals Holding Co., Ltd. engages in the research and development, manufacture, distribution, and retail of pharmaceutical products. The company was founded on January 18, 1994 and is headquartered in Shanghai, China.

Bonntai (Shandong) Biomedical Technology Group Co., Ltd., established on 2003-09-19, Business scope includes biomedicine,chemicals(Does not contain human stem cells,Genetic Diagnosis and Therapy)technology development,technical consulting,technology transfer,Technology Promotion;Health Advisory(Does not include medical and psychological counseling);production of medicines;medical instruments,food(The operating permit)processing,Sales.(The above operating items do not include items subject to special management measures for foreign investment access)(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Beijing Konruns Pharmaceutical Co., Ltd. engages in the research, development, production, and marketing of new drugs, with a focus on new special drugs. The company was founded by Xi Juan Wang and Jian Hua Liu on September 3, 2003 and is headquartered in Beijing, China.

QHSLab, Inc. operates as a medical device technology and software as a service company. It focuses on enabling primary care physicians to increase their revenues by providing them with relevant, value-based tools to evaluate, and treat chronic disease through reimbursable procedures. Its products will enable physicians to diagnose and treat patients with chronic diseases which they historically have referred to specialists. The company was founded on September 1, 1983 and is headquartered in West Palm Beach, FL.

Acadia Pharmaceuticals Inc. is a biopharmaceutical company focused on the development and commercialization of small molecule drugs for the treatment of central nervous system disorders. The Company maintains two wholly owned subsidiaries: Acadia Pharmaceuticals AB based in Malmo, Sweden and Acadia Pharmaceuticals A/S based in Denmark. The Company is developing a portfolio consisting of four product candidates, including the compound, pimavanserin, which it is developing for three separate neurological and psychiatric indications in collaboration with Biovail Laboratories International SRL (Biovail), a subsidiary of Biovail Corp. The indications are Parkinson's disease psychosis, which is in Phase III development, adjunctive therapy in schizophrenia, and Alzheimer's disease psychosis, for which it is initiating a Phase II feasibility study.

Shandong United Pesticide Industry Co., Ltd., established on 1995-07-31, Business scope includes pesticides,fungicide,Production of herbicide pesticides,Processing and sales of self-produced pesticides;Hydrochloric acid production.(The validity period is subject to the license).Technology development and information consultation;chemical industry,Sales of instrumentation;Import and export business within the scope of filing.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Jiangsu Kaiyuan Pharmaceutical Co., Ltd., established on 2016-01-29, Business scope includes licensed projects:Inspection and testing service;pharmaceutical production;Drug internet information service;Internet Information Service for Medical Devices;Drug Wholesale;Drug import and export;Import and export agency;Import and export(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results) General project:Medical Research and Experimental Development;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;sales agent;Sales of Class I Medical Devices;Sales of Class II Medical Devices;Chemical product sales(No licensed chemical products);Production of protective equipment for medical personnel(Ι class medical device);daily mask(non-medical)Production;daily mask(non-medical)Sales;Sales of labor protection products;Wholesale of protective equipment for medical staff(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)